These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10462190)

  • 21. Mrz 2/579, a fast kinetic NMDA channel blocker, reduces the development of morphine tolerance in awake rats.
    Houghton AK; Parsons CG; Headley MP
    Pain; 2001 Apr; 91(3):201-207. PubMed ID: 11275375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of NMDA receptor antagonists on morphine tolerance: a c-Fos study in the lumbar spinal cord of the rat.
    Le Guen S; Catheline G; Besson JM
    Eur J Pharmacol; 1999 May; 373(1):1-11. PubMed ID: 10408246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of systemic, intracerebral, or intrathecal administration of an N-methyl-D-aspartate receptor antagonist on associative morphine analgesic tolerance and hyperalgesia in rats.
    McNally GP; Westbrook RF
    Behav Neurosci; 1998 Aug; 112(4):966-78. PubMed ID: 9733203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NMDA antagonist modulation of morphine antinociception in female vs. male rats.
    Craft RM; Lee DA
    Pharmacol Biochem Behav; 2005 Apr; 80(4):639-49. PubMed ID: 15820534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist.
    Kolesnikov Y; Pasternak GW
    J Pharmacol Exp Ther; 1999 Jul; 290(1):247-52. PubMed ID: 10381783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice.
    Geter-Douglass B; Witkin JM
    Psychopharmacology (Berl); 1999 Oct; 146(3):280-9. PubMed ID: 10541728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of short-acting NMDA receptor antagonist MRZ 2/576 on morphine tolerance development in mice.
    Belozertseva IV; Danysz W; Bespalov AY
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jun; 361(6):573-7. PubMed ID: 10882030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia.
    Harris AC; Rothwell PE; Gewirtz JC
    Psychopharmacology (Berl); 2008 Mar; 196(4):649-60. PubMed ID: 18026718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
    Lutfy K; Doan P; Weber E
    Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
    Juni A; Klein G; Kest B
    Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat.
    Dunbar SA; Pulai IJ
    J Pharmacol Exp Ther; 1998 Feb; 284(2):678-86. PubMed ID: 9454814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
    Allen RM; Dykstra LA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-allodynic interactions between NMDA receptor channel blockers and morphine or clonidine in neuropathic rats.
    Malyshkin AA; Medvedev IO; Danysz W; Bespalov AY
    Eur J Pharmacol; 2005 Sep; 519(1-2):80-5. PubMed ID: 16109402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketanserin reverses dizocilpine-suppression of morphine dependence but not tolerance in mice.
    Ninan I; Kulkarni SK
    Brain Res; 2000 Sep; 876(1-2):215-9. PubMed ID: 10973613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists--in vitro characterisation.
    Parsons CG; Danysz W; Quack G
    Amino Acids; 2000; 19(1):157-66. PubMed ID: 11026484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the non-competitive NMDA-receptor antagonist memantine on morphine- and cocaine-induced potentiation of lateral hypothalamic brain stimulation reward.
    Tzchentke TM; Schmidt WJ
    Psychopharmacology (Berl); 2000 Apr; 149(3):225-34. PubMed ID: 10823402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of memantine on estrogen-dependent acute tolerance to the morphine analgesia in female rats.
    Shekunova EV; Bespalov AY
    Eur J Pharmacol; 2006 Mar; 535(1-3):78-85. PubMed ID: 16546163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of linalool on morphine tolerance and dependence in mice.
    Hosseinzadeh H; Imenshahidi M; Hosseini M; Razavi BM
    Phytother Res; 2012 Sep; 26(9):1399-404. PubMed ID: 22318903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
    Fischer BD; Carrigan KA; Dykstra LA
    J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex-related differences in the enhancement of morphine antinociception by NMDA receptor antagonists in rats.
    Holtman JR; Jing X; Wala EP
    Pharmacol Biochem Behav; 2003 Sep; 76(2):285-93. PubMed ID: 14592680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.